Table 2. Unadjusted event rates for cancer mortality (in-trial and post-trial combined) by eGFR and cancer type.
| Total | eGFR ≥ 90 | eGFR (60 – 89.9) | eGFR (45 – 59.9) | eGFR < 45 | |
|---|---|---|---|---|---|
| Number of events Event rate/100 (SE) 5-years 10-years |
Number of events Event rate/100 (SE) 5-years 10-years |
Number of events Event rate/100 (SE) 5-years 10-years |
Number of events Event rate/100 (SE) 5-years 10-years |
Number of events Event rate/100 (SE) 5-years 10-years |
|
| Cancer mortality | 2,338 3.33 (0.10) 8.25 (0.17) |
591 3.13 (0.20) 7.90 (0.33) |
1,266 3.07 (0.13) 7.71 (0.22) |
357 4.12 (0.32) 10.11 (0.54) |
124 6.04 (0.73) 13.19 (1.20) |
| Prostate | 191 0.51 (0.06) 1.29 (0.10) |
40 0.48 (0.11) 1.09 (0.18) |
104 0.40 (0.07) 1.12 (0.12) |
36 0.82 (0.21) 2.30 (0.41) |
11 1.75 (0.61) 2.70 (0.82) |
| Lung | 719 1.10 (0.06) 2.61 (0.10) |
191 1.09 (0.12) 2.59 (0.19) |
389 0.96 (0.08) 2.46 (0.13) |
110 1.62 (0.20) 3.08 (0.30) |
29 1.35 (0.36) 3.45 (0.67) |
| Colon | 230 0.33 (0.03) 0.87 (0.06) |
54 0.25 (0.06) 0.73 (0.10) |
132 0.35 (0.05) 0.90 (0.08) |
31 0.33 (0.09) 0.92 (0.18) |
13 0.65 (0.25) 1.29 (0.42) |
| Breast | 107 0.28 (0.05) 0.81 (0.08) |
29 0.30 (0.09) 0.82 (0.16) |
50 0.24 (0.06) 0.68 (0.10) |
21 0.40 (0.14) 1.25 (0.29) |
7 0.32 (0.23) 1.06 (0.48) |
| Urinary-tract | 110 0.15 (0.02) 0.39 (0.04) |
23 0.08 (0.03) 0.32 (0.07) |
59 0.14 (0.03) 0.34 (0.05) |
18 0.22 (0.08) 0.55 (0.14) |
10 0.56 (0.23) 1.12 (0.37) |
| Hematopoietic | 179 0.25 (0.03) 0.64 (0.05) |
39 0.20 (0.05) 0.52 (0.09) |
104 0.25 (0.04) 0.66 (0.07) |
30 0.36 (0.10) 0.78 (0.16) |
6 0.30 (0.18) 0.67 (0.28) |
| Other | 802 1.14 (0.06) 2.94 (0.11) |
215 1.15 (0.12) 3.01 (0.21) |
428 1.08 (0.08) 2.66 (0.13) |
111 1.05 (0.16) 3.44 (0.34) |
48 2.38 (0.47) 5.58 (0.86) |